Literature DB >> 1435751

Indirect effect of guanine nucleotides on antagonist binding to A1 adenosine receptors: occupation of cryptic binding sites by endogenous vesicular adenosine.

M R Prater1, H Taylor, R Munshi, J Linden.   

Abstract

Guanine nucleotides such as guanosine 5'-(3-O-thio)triphosphate (GTP gamma S) have been found to increase the binding of antagonists to adenosine A1 receptors. This response can be attributed either to a direct effect of GTP on receptors to increase antagonist affinity or to an indirect effect to decrease the affinity of receptors for a pool of endogenous adenosine that cannot be readily removed from membranes. In this study, adenosine content was measured in preparations of membranes and 3-[(3-cholamidopropyl)dimethylamino]-1-propanesulfonate (CHAPS)-solubilized receptors by a sensitive radioimmunoassay. In both preparations, pools of adenosine (2.5-10 pmol/mg of protein) were detected that were resistant to deamination by added adenosine deaminase (0.5-3 units/ml) unless membrane lipids were first dissolved in acetone. Electron microscopic examination of crude CHAPS-solubilized receptors revealed the existence of small vesicles (< 1 microns in diameter). Furthermore, most "solubilized" receptors were retained by a 0.1-microns filter. The effects of GTP gamma S were evaluated on the binding of an antagonist, 3-(4-amino-3-125I-phenethyl)-1-propyl-8-cyclopentylxanthine (125I-BW-A844U), to A1 receptors of bovine brain membranes, receptors solubilized in CHAPS (crude solubilized), or receptors partially co-purified with G proteins by agonist affinity chromatography (partially purified). GTP gamma S (10 microM) increased antagonist binding to membranes (20-50%) and crude CHAPS-solubilized receptors (> 200%) but increased binding to partially purified receptors by only 10-15%. GTP gamma S decreased agonist (125I-N6-aminobenzyladenosine) binding and increased antagonist Bmax, but did not significantly decrease (5%) the dissociation rate of the antagonist. Omission of Mg2+ mimicked the effects of GTP gamma S on agonist and antagonist binding and increased both the association and dissociation rates of 125I-BW-A844U. These data suggest that a Mg(2+)-dependent GTP gamma S-induced increase in antagonist binding to membranes and solubilized receptors is primarily due to unmasking of cryptic binding sites occupied by contaminating vesicular adenosine. These findings are consistent with the observation that adenosine receptor antagonists have been found to have little or no inverse agonist physiological effects in well oxygenated tissues.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1435751

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  9 in total

1.  Palmitoylation of the recombinant human A1 adenosine receptor: enhanced proteolysis of palmitoylation-deficient mutant receptors.

Authors:  Z Gao; Y Ni; G Szabo; J Linden
Journal:  Biochem J       Date:  1999-09-01       Impact factor: 3.857

2.  Alkylxanthine adenosine antagonists and epileptiform activity in rat hippocampal slices in vitro.

Authors:  A J Chesi; T W Stone
Journal:  Exp Brain Res       Date:  1997-02       Impact factor: 1.972

3.  Afferent arteriolar vasodilator effect of adenosine predominantly involves adenosine A2B receptor activation.

Authors:  Ming-Guo Feng; L Gabriel Navar
Journal:  Am J Physiol Renal Physiol       Date:  2010-05-12

4.  Solubilized rabbit striatal A2a-adenosine receptors: stability and antagonist binding.

Authors:  X D Ji; K A Jacobson
Journal:  Arch Biochem Biophys       Date:  1993-09       Impact factor: 4.013

5.  The amphiphilic peptide adenoregulin enhances agonist binding to A1-adenosine receptors and [35S]GTP gamma S to brain membranes.

Authors:  R W Moni; F S Romero; J W Daly
Journal:  Cell Mol Neurobiol       Date:  1995-08       Impact factor: 5.046

6.  A1 adenosine receptor inhibition of cyclic AMP formation and radioligand binding in the guinea-pig cerebral cortex.

Authors:  S P Alexander; A R Curtis; D A Kendall; S J Hill
Journal:  Br J Pharmacol       Date:  1994-12       Impact factor: 8.739

7.  An optimized approach to study endocannabinoid signaling: evidence against constitutive activity of rat brain adenosine A1 and cannabinoid CB1 receptors.

Authors:  Juha R Savinainen; Susanna M Saario; Riku Niemi; Tomi Järvinen; Jarmo T Laitinen
Journal:  Br J Pharmacol       Date:  2003-11-17       Impact factor: 8.739

8.  The effects of saponin on the binding and functional properties of the human adenosine A1 receptor.

Authors:  F R Cohen; S Lazareno; N J Birdsall
Journal:  Br J Pharmacol       Date:  1996-04       Impact factor: 8.739

9.  Allosteric coupling from G protein to the agonist-binding pocket in GPCRs.

Authors:  Brian T DeVree; Jacob P Mahoney; Gisselle A Vélez-Ruiz; Soren G F Rasmussen; Adam J Kuszak; Elin Edwald; Juan-Jose Fung; Aashish Manglik; Matthieu Masureel; Yang Du; Rachel A Matt; Els Pardon; Jan Steyaert; Brian K Kobilka; Roger K Sunahara
Journal:  Nature       Date:  2016-06-29       Impact factor: 49.962

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.